This compound is a modified nucleoside protected with a phthalimide group, used as a building block in the synthesis of oligonucleotides. It features a cytosine base attached to a modified sugar ring, with the 5'-hydroxyl group masked by the phthalimide moiety for selective deprotection during solid-phase synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2,4-Dichloro-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine
pharmaceutical intermediate
Acarbose Impurity E
pharmaceutical intermediate
Acarbose EP Impurity B
pharmaceutical intermediate
2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate
pharmaceutical intermediate
2-[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxyisoindole-1,3-dione
GSLQDLDOBMUSCB-OUCADQQQSA-N
C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)ON3C(=O)C4=CC=CC=C4C3=O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.